NEUROENDOCRINE NEOPLASM

Clinical trials for NEUROENDOCRINE NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new NEUROENDOCRINE NEOPLASM trials appear

Sign up with your email to follow new studies for NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 8 Completed 1

Experimental drug targets Hard-to-Treat neuroendocrine cancers

Disease control Not yet recruiting

This trial tests an experimental drug called CTX-471 in people with advanced neuroendocrine tumors that have a specific marker (NCAM) and have stopped responding to standard treatments. Participants receive the drug by IV every two weeks. The study aims to see if the drug can shr…

Matched conditions: NEUROENDOCRINE NEOPLASM

Phase: PHASE2 • Sponsor: Compass Therapeutics • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC

NEUROENDOCRINE NEOPLASM

Get alerted when new NEUROENDOCRINE NEOPLASM trials appear

Experimental drug targets Hard-to-Treat neuroendocrine cancers